| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 27 |
| 1 | METHOTREXATE | 22 |
| 2 | ROSUVASTATIN | 17 |
| 3 | ABATACEPT | 16 |
| 4 | RITUXIMAB | 15 |
| 5 | ANAKINRA | 14 |
| 6 | CERTOLIZUMAB PEGOL | 14 |
| 7 | FUROSEMIDE | 14 |
| 8 | HYDROXYCHLOROQUINE SULFATE | 14 |
| 9 | LEFLUNOMIDE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 1 | BARICITINIB | 13 | 0.0043 |
| 2 | POTASSIUM IODIDE | 4 | 0.0027 |
| 3 | EPHEDRINE HYDROCHLORIDE | 1 | 0.0022 |
| 4 | DAPRODUSTAT | 4 | 0.0020 |
| 5 | EDARAVONE | 3 | 0.0019 |
| 6 | EDOXABAN TOSYLATE | 10 | 0.0015 |
| 7 | ANDEXANET ALFA | 1 | 0.0014 |
| 8 | BODY CLEANSER | 1 | 0.0014 |
| 9 | LEMBOREXANT | 4 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 4 | 0.0018 |
| 2 | Chloride Channel Activator [EPC] | 8 | 0.0008 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 14 | 0.0008 |
| 4 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 5 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 6 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 7 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Vasopressin V2 Receptor Antagonist [EPC] | 6 | 0.0004 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |